Two new studies published last month showed exciting new advances in the treatment of melanoma. We know that patients who have a local melanoma resected with lymph node involvement have a very high risk of relapse (over 50%) without any further treatment. These two studies looked at adding systemic therapy—either targeted therapy or immunotherapy—to see if… Read more »
